4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000054
President & COO sold 2,303 shares at an average $15.09 ($34,753)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2024-09-06 | Sale 10b5-1 | −399 | $15.19 | $6,063 | 127,900 | D: show line 1 in the form |
| Dowden Nathan J President & COO | 2024-09-09 | Sale 10b5-1 | −1,904 | $15.07 | $28,690 | 125,996 | D: show line 2 in the form |
| Open-market sales · 2,303 sh · avg $15.09 · $34,753 | |||||||
Loading xslF345X05/wk-form4_1726000407.xml…